Epirubicin and alanine aminotransferase increased Patient Reports February 12, 2012

Epirubicin Side Effects Report #4603212-7
Epirubicin side effect was reported by a Physician from on Feb 22, 2005. Female patient, 55 years of age, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, brain scan abnormal, coma, haemoglobin decreased, lung disorder, neutropenia, platelet count decreased, pyrexia. Epirubicin dosage: 160 MG (SINGLE DOSE), ORAL. During the same period patient was treated with DEXRAZOXANE, FLUOROURACIL, CYCLOPHOSPHAMIDE, GRANISETRON, ONDANSETRON, CORTICOSTEROIDS. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #4761069-8
Epirubicin side effect was reported by a Physician from FRANCE on Aug 22, 2005. Female patient, 55 years of age, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cerebral disorder, coma, febrile bone marrow aplasia, hypotonia, lung disorder, myotonia. Epirubicin dosage: 160 MG (SINGLE DOSE), ORAL. During the same period patient was treated with DEXRAZOXANE, FLUOROURACIL, CYCLOPHOSPHAMIDE, KYTRIL, ZOPHREN, CORTICOSTEROIDS. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #5006839-6
Epirubicin side effect was reported by a Physician from FRANCE on May 03, 2006. Female patient, 55 years of age, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, brain scan abnormal, coma, depressed level of consciousness, haemoglobin decreased, hypotonia, lung disorder. Epirubicin dosage: 160 MG (SINGLE DOSE), ORAL. During the same period patient was treated with DEXRAZOXANE, FLUOROURACIL, CYCLOPHOSPHAMIDE, KYTRIL, ZOFRAN, CORTICOSTEROIDS. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #5729286-8
Epirubicin side effect was reported by a Health Professional from UNITED KINGDOM on Apr 24, 2008. Female patient, 31 years of age, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, malaise, nausea . Epirubicin dosage: unknown. During the same period patient was treated with ENDOXAN, FLUOROURACIL. Patient recovered.


Epirubicin Side Effects Report #5730374-0
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 24, 2008. Female patient, 31 years of age, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, malaise, nausea . Epirubicin dosage: unknown. During the same period patient was treated with FLUOROURACIL, CYCLOPHOSPHAMIDE. Patient recovered.

Epirubicin Side Effects Report #5567553-1
Epirubicin side effect was reported by a Physician from JAPAN on Dec 07, 2007. Male patient, weighting 132.3 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, lymphocyte count decreased, malaise, pyrexia. Epirubicin dosage: unknown. During the same period patient was treated with EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE, DECADRON. Patient recovered.

Epirubicin Side Effects Report #5974810-3
Epirubicin side effect was reported by a Consumer or non-health professional from JAPAN on Nov 26, 2008. Male patient, 72 years of age, was treated with Epirubicin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, platelet count decreased. Epirubicin dosage: unknown. During the same period patient was treated with LIPIODOL. Patient recovered.